UPDATE: The codevelopment agreement between Savant HWP and Humanigen for the US approval of benznidazole is essentially moot now, as the FDA granted accelerated...
Read More
On December 21, 2016, Senators Susan Collins (R-Maine) and Claire McCaskill (D-Missouri), the respective Chairman and Ranking Member of the Senate Aging Committee,...
Read More
This is a MUST READ from Zachary Brennen at RAPS/Regulatory Focus on the review and potential reauthorization of the controversial priority review voucher (PRV) program...
Read MoreIn a press release yesterday, Turing Pharmaceuticals—the sole US seller of Daraprim (pyrimethamine)—announced its development of “several” NMEs for the...
Read MoreHere is a recent BioFlash podcast, in which Kalobios (KBIO) CEO Cameron Durrant provided an update on the development plans for benznidazole and had some interesting...
Read MoreThis is a belated examination of an August 24th Forbes interview with the head of R&D at Turing Pharmaceuticals, Dr. Eliseo Salinas. Clearly Dr. Salinas is...
Read More
